Lahore General Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT07347132
Bladder cancer that has not invaded the bladder muscle often returns after treatment, creating repeated procedures and ongoing anxiety for patients. The standard initial treatment is transurethral resection of bladder tumour (TURBT), in which visible tumours are removed through a telescope passed into the bladder. Conventional TURBT usually removes the tumour in multiple pieces, which may reduce specimen quality for laboratory assessment and may increase the chance that small tumour fragments remain or spread during removal. En bloc TURBT is a newer technique that aims to remove the tumour in one intact piece, which may improve the quality of the tissue specimen for accurate staging and grading, allow better assessment of surgical margins, and potentially reduce recurrence.
This randomized controlled trial was conducted in the Department of Urology, Lahore General Hospital and PGMI, Lahore. A total of 116 adults (18 to 60 years) with non-muscle invasive bladder cancer were enrolled and randomly assigned to en bloc TURBT or conventional TURBT (58 patients per group). Resected specimens were evaluated by pathologists who was not be informed of the surgical technique. The study was compare key pathological outcomes, including the presence of detrusor muscle in the specimen, histological grade, tumour stage accuracy, specimen integrity, and the ability to assess lateral and deep resection margins. Participants were followed for 15 months, with surveillance at 3-month intervals.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Complete en bloc endoscopic resection of a non-muscle invasive bladder tumour (≤1.5 cm) as one piece, aiming to preserve specimen integrity and allow assessment of deep and lateral margins.
Other names: En bloc resection of bladder tumour (ERBT)
Piecemeal endoscopic resection of a non-muscle invasive bladder tumour by removing the lesion in multiple pieces, as per standard conventional technique.
Other names: Conventional transurethral resection of bladder tumour (cTURBT)
Time frame: Up to 15 months after surgery, assessed at 3, 6, 9, 12 and 15 months
Proportion of participants with histologically confirmed recurrence of non-muscle invasive bladder cancer detected by cystoscopy and biopsy after complete initial resection.
Lahore General Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03081858
Bladder Cancer, Bladder Cancer Cell Transitional
Tucson, Arizona, United States
View Trial DetailsNCT03973671
Carcinoma, Disease Attributes
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT04172675
Carcinoma, Female Urogenital Diseases
Tucson, Arizona, United States
View Trial DetailsNCT02695771
Carcinoma, Female Urogenital Diseases
Grand Rapids, Michigan, United States
View Trial Details